{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:59:59Z","timestamp":1787241599572,"version":"build-2736575974"},"reference-count":14,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Microbial Drug Resistance"],"published-print":{"date-parts":[[2011,3]]},"abstract":"<jats:p>\n                    The analysis comprised a total of 97,843 U.S. isolates from the Surveillance Network\n                    <jats:sup>\u00ae<\/jats:sup>\n                    database for the period 1996\u20132008. Penicillin resistance, when defined using the old Clinical Laboratory Standards Institute breakpoint (\u22652\u2009\u03bcg\/ml), had an initial rise that started in 1996, peaked in 2000, declined until 2003, and rebounded through 2008 (15.6%, 23.2%, 15.4%, and 16.9%, respectively). Using the new Clinical Laboratory Standards Institute criteria and applying a breakpoint of \u22658\u2009\u03bcg\/ml to blood and bronchial isolates, resistance was unchanged (0.24% in 2003) but rose to 1.52% in 2008. Using the new meningitis criteria (\u22650.12\u2009\u03bcg\/ml), resistance prevalence was 34.8% in 2008, whereas it was 12.3% using the old criteria (\u22652\u2009\u03bcg\/ml) for cerebrospinal fluid isolates. The rise, fall, and subsequent rebound of penicillin resistance in the United States, presumably influenced by the introduction of the conjugate pneumococcal vaccine, is clearly seen with the old definition, but only the rebound is seen when the new criteria are applied. In the postvaccine period, isolates with minimum inhibitory concentrations of 1 and 2\u2009\u03bcg\/ml decline, whereas those with minimum inhibitory concentrations of 0.12\u20130.5 increase, which may signal the loss of resistant vaccine serotypes and the acquisition of resistance by nonvaccine serotypes.\n                  <\/jats:p>","DOI":"10.1089\/mdr.2010.0129","type":"journal-article","created":{"date-parts":[[2010,11,30]],"date-time":"2010-11-30T17:29:24Z","timestamp":1291138164000},"page":"47-52","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":19,"title":["Impact of New Clinical Laboratory Standards Institute\n                    <i>Streptococcus pneumoniae<\/i>\n                    Penicillin Susceptibility Testing Breakpoints on Reported Resistance Changes over Time"],"prefix":"10.1177","volume":"17","author":[{"given":"Robertino M.","family":"Mera","sequence":"first","affiliation":[{"name":"GlaxoSmithKline"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda A.","family":"Miller","sequence":"additional","affiliation":[{"name":"GlaxoSmithKline"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Amrine-Madsen","sequence":"additional","affiliation":[{"name":"GlaxoSmithKline"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel F.","family":"Sahm","sequence":"additional","affiliation":[{"name":"Eurofins Medinet"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2011,3]]},"reference":[{"key":"e_1_3_2_2_2","volume-title":"Program and Abstracts of the 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy (San Diego)","author":"Ambrose P.","year":"2002","unstructured":"Ambrose P., , Craig W., , Bhavani S., , Dudley M. 2002. Pharmacodynamic comparisons of different dosing regimens of penicillin G against penicillin-susceptible and -resistant pneumococci [abstract A-1263] Program and Abstracts of the 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy (San Diego) American Society for Microbiology, Washington, DC."},{"key":"e_1_3_2_3_2","volume-title":"CLSI Document M100-S18","author":"Clinical, Laboratory Standards Institute","year":"2008","unstructured":"Clinical, Laboratory Standards Institute. 2008. Performance Standards for Antimicrobial Susceptibility Testing; Eighteenth Informational Supplement. CLSI Document M100-S18. Clinical and Laboratory Standards Institute: Wayne, PA."},{"key":"e_1_3_2_4_2","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/S0264-410X(99)00122-X","article-title":"The burden of pneumococcal disease among adults in developed and developing countries: what is and is not known","volume":"17","author":"Fedson D.","year":"1999","unstructured":"Fedson D., , Scott J., , Scott G. 1999. The burden of pneumococcal disease among adults in developed and developing countries: what is and is not known. Vaccine, 17:S11\u2013S18.","journal-title":"Vaccine"},{"key":"e_1_3_2_5_2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1086\/324526","article-title":"Appropriate use of antimicrobials for drug resistant pneumonia: focus on the significance of beta-lactam-resistant Streptococcus pneumoniae","volume":"1","author":"File T.","year":"2002","unstructured":"File T. 2002. Appropriate use of antimicrobials for drug resistant pneumonia: focus on the significance of beta-lactam-resistant Streptococcus pneumoniae. Clin. Infect. Dis., Suppl 1:17\u201326.","journal-title":"Clin. Infect. Dis."},{"key":"e_1_3_2_6_2","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1086\/500142","article-title":"The clinical relevance of penicillin-resistant Streptococcus pneumoniae: a new perspective","volume":"42","author":"File T.","year":"2006","unstructured":"File T.Jr., , Tan J., , Boex J. 2006. The clinical relevance of penicillin-resistant Streptococcus pneumoniae: a new perspective. Clin. Infect. Dis., 42:798\u2013800.","journal-title":"Clin. Infect. Dis."},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1089\/mdr.2009.0056"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1089\/mdr.2008.0782"},{"key":"e_1_3_2_9_2","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1001\/archinte.161.21.2538","article-title":"A fresh look at the definition of susceptibility of Streptococcus pneumoniae to beta-lactam antibiotics","volume":"161","author":"Musher D.","year":"2001","unstructured":"Musher D., , Bartlett J., , Doern G. 2001. A fresh look at the definition of susceptibility of Streptococcus pneumoniae to beta-lactam antibiotics. Arch. Intern. Med., 161:2538\u20132544.","journal-title":"Arch. Intern. Med."},{"key":"e_1_3_2_10_2","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1056\/NEJM199508243330802","article-title":"Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain","volume":"333","author":"Palleres R.","year":"1995","unstructured":"Palleres R., , Linares J., , Vadillo M., , Cabellos C., , Manresa F., , Viladrich P. 1995. Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N. Engl. J. Med., 333:474\u2013480.","journal-title":"N. Engl. J. Med."},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1086\/497594"},{"key":"e_1_3_2_12_2","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1001\/jama.285.13.1729","article-title":"Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995\u20131998. Opportunities for prevention in the conjugate vaccine era","volume":"285","author":"Robinson K.","year":"2001","unstructured":"Robinson K., , Baughman W., , Rothrock G., , Whytney C. 2001. Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995\u20131998. Opportunities for prevention in the conjugate vaccine era. JAMA, 285:1729\u20131735.","journal-title":"JAMA"},{"key":"e_1_3_2_13_2","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1086\/500140","article-title":"The impact of penicillin resistance on short-term mortality in hospitalized adults with pneumococcal pneumonia: a systematic review and meta-analysis","volume":"42","author":"Tleyjeh I.M.","year":"2006","unstructured":"Tleyjeh I.M., , Tlaygeh H., , Hejal R., , Montori V., , Baddour L. 2006. The impact of penicillin resistance on short-term mortality in hospitalized adults with pneumococcal pneumonia: a systematic review and meta-analysis. Clin. Infect. Dis., 42:788\u2013797.","journal-title":"Clin. Infect. Dis."},{"key":"e_1_3_2_14_2","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1086\/598975","article-title":"Rationale for revised penicillin susceptibility breakpoints versus Streptococcus pneumoniae: coping with antimicrobial susceptibility in an era or resistance","volume":"48","author":"Weinstein M.P.","year":"2009","unstructured":"Weinstein M.P., , Klugman K., , Jones R. 2009. Rationale for revised penicillin susceptibility breakpoints versus Streptococcus pneumoniae: coping with antimicrobial susceptibility in an era or resistance. Clin. Infect. Dis., 48:1596\u20131600.","journal-title":"Clin. Infect. Dis."},{"key":"e_1_3_2_15_2","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1086\/377534","article-title":"An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome. International Pneumococcal Study Group","volume":"37","author":"Yu V.L.","year":"2003","unstructured":"Yu V.L., , Chiou C., , Feldman C., , Ortqvist A., , Rello J., , Morris A., , Baddour L., , Luna C., , Snydman D., , Klugman K. 2003. An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome. International Pneumococcal Study Group. Clin. Infect. Dis., 37:230\u2013237.","journal-title":"Clin. Infect. Dis."}],"container-title":["Microbial Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/mdr.2010.0129","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/mdr.2010.0129","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/mdr.2010.0129","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T20:26:00Z","timestamp":1777667160000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.1089\/mdr.2010.0129"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["10.1089\/mdr.2010.0129"],"URL":"https:\/\/doi.org\/10.1089\/mdr.2010.0129","relation":{},"ISSN":["1076-6294","1931-8448"],"issn-type":[{"value":"1076-6294","type":"print"},{"value":"1931-8448","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}